Drinking milk can prevent garlic breath

The Institute of Food Technologists (IFT) today announced the public release of their report for the U.S. Food and Drug Administration (FDA) focused on the outcomes of two pilot projects designed to test and study various product tracing practices for fresh produce and processed foods.

This report on the pilots, which was required by the Food Safety Modernization Act (FSMA), offers recommendations to the FDA on how to improve product tracing in a way that benefits all stakeholders. The report provides important findings to help regulators resolve foodborne illness outbreaks earlier and enable the food industry to respond to them quicker. As a result, the public health impact of an outbreak will be greatly reduced. Based on eight case studies of previous outbreaks, improved product tracing had the potential to reduce the public health impact by up to 55 percent of total illnesses and reduce the economic impact by up to $14 million per outbreak.

The results of the pilots also suggest that if a food company improves their ability to trace products, the company can expect to also achieve improved business processes, increase supply chain confidence and possibly expand their markets. Many companies in the food industry consider product tracing a subset of supply chain operations, and product tracing may not be a dominant consideration when making investment decisions. However, the threat of not having product tracing capabilities in the event of a foodborne illness outbreak represents significant risks to a firm.

Pilot study findings and recommendations

As part of the report submitted to FDA, IFT conducted a pilot looking at fresh produce and another pilot for processed foods. Tomatoes were selected for the fresh produce pilot, and foods consisting of chicken, peanuts and/or spices were selected for the processed food pilot. Foods selected for the pilots had been associated with outbreaks between 2005 and 2010. Key findings from IFT's analysis of current product tracing practices indicate the following challenges associated with outbreak investigations:

• Tedious and difficult to sort through hundreds of pages of documents
• Confusion when data definition is lacking
• Inconsistent item descriptions
• Wrong or incomplete information cause delays
• Companies operating under multiple names are difficult to identify as sources

Additional IFT recommendations to the FDA include the following:

• Clearly identify the types of data that industry needs to provide during an outbreak investigations
• Require each member of the food supply chain to develop, document and implement a product tracing plan
• Pursue the adoption of a technology platform to allow the FDA to efficiently aggregate and analyze data reported in response to regulatory requests
• Coordinate traceback investigations and develop response protocols between and among state and local health and regulatory agencies
• Offer extensive outreach and education around future regulations and expectations

The FDA is soliciting input on the IFT report and will issue its own recommendations in a report to Congress. The full IFT report and additional materials are accessible at www.ift.org/traceability.